4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Genfit S.A. (GNFT) operates in the Biotechnology industry and is headquartered in Loos, France with about 161 employees. Its market capitalization is roughly €652 million. In the fiscal year ended 2025-12-31, GNFT reported €65M in revenue and (€86M) in net income.
Genfit S.A., together with its subsidiaries, engages in the research and development of medicines and diagnostic solutions in France and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €65M | €67M | €29M | €20M | — |
| Gross Profit | €65M | €67M | €28M | €20M | — |
| Operating Income (EBIT) | (€54M) | €3M | (€27M) | (€27M) | — |
| Net Income | (€86M) | €2M | (€29M) | (€24M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | €0M | €0M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €159M | €151M | €174M | €216M | — |
| Total Liabilities | €182M | €82M | €106M | €121M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GNFT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms